StockData
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

PROCEPT BioRobotics Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$18.28+0.71 (+4.04%)

Close on Oct 19, 2026

Market cap
$1.04B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 3, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 4, 2026After market close$94.50M$-0.47–
Q1 FY2026
Ended Mar 31, 2026
Apr 29, 2026After market close$83.10M––
Q4 FY2025
Ended Dec 31, 2025
Feb 25, 2026After market close$76.40M––
Q3 FY2025
Ended Sep 30, 2025
Nov 4, 2025After market close$83.30M––
Q2 FY2025
Ended Jun 30, 2025
Aug 6, 2025After market close–––
Q1 FY2025
Ended Mar 31, 2025
Apr 24, 2025Before market open$69.20M––
Q4 FY2024
Ended Dec 31, 2024
Feb 25, 2025After market close$68.20M––
Q3 FY2024
Ended Sep 30, 2024
Oct 28, 2024Before market open$58.40M––
Q2 FY2024
Ended Jun 30, 2024
Aug 1, 2024After market close–––
Q1 FY2024
Ended Mar 31, 2024
May 1, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 27, 2024After market close–––

Company guidance

Outlook given with results on Aug 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted EBITDAnon-GAAPfull year 2026-$35.00M to -$30.00MLowered
gross marginfull year 202665%Maintained
U.S. procedure volumefull year 202654,000 to 56,000New
revenuefull year 2026$390.00M to $410.00MMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements PROCEPT BioRobotics filed with the SEC